top of page

Safe, effective Esketamine Therapy in South Jersey(coming soon)

spravato-therapy-research-scaled.jpg

Did you know that Ketamine has been an FDA-Approved anesthetic since the 1960s?

It's totally true! The use of Spravato®(Esketamine) for mood disorders and neuropathic pain, however is a discovery only made within the last three decades...but it has proven to be profoundly effective and a major development for psychiatry as an industry!

Results in as little as 1 hour!

Due to the breakthrough nature of Esketamine as a psychiatric treatment, leaps and bounds of progress have been made. The nasal inhaler method of Spravato Esketamine Therapy is rapid and can provide relief within an hour or two, and after a SERIES of treatments, the effects can last weeks to months!

From anxiety to depression, OCD to PTSD.

ketamine-2-1ea0cad420a4f5f45a5b33afa819eee3536fa353-s1100-c50.jpg

Why Spravato®?

download.jpg

SPRAVATO® is the first and only NMDA* receptor antagonist approved in conjunction with an oral antidepressant for adult patients with treatment-resistant depression (TRD).

No injections. No fear of blood or pain. The most-advanced Esketamine-delivery possible.

Image by Milad Fakurian

Billions. Of. Neurons.

The brain's Cerebral Cortex, which is just ONE part of the body's most powerful organ contains up to 25 BILLION neurons. These are responsible for communicating with each other via nuerotransmitters which are chemicals that serves as the messenger. Ketamine is what's called an NMDA receptor and interacts with the body's natural glutamine. Linking these two can increase what's called Neuroplasticity, or the brain's ability to form new connections between neurons.

SCIENCE!

Primary Treatments

  • Depression

  • Anxiety

  • PTSD

  • Chronic Pain

And much more!

SPRAVATO® therapy has the ability to work quickly and safely. Within merely hours of the first dosage, compared to WEEKS in conventional medication, SPRAVATO® has proven itself to be a groundbreaking treatment since hitting the market.

bottom of page